Skip to Content

kneat.com Inc FOBK

Morningstar Rating
CAD 2.82 −0.02 (0.70%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FOBK is trading at a 569% premium.
Price
€2.83
Fair Value
€8.37
Uncertainty
Very High
1-Star Price
€9.62
5-Star Price
€5.37
Economic Moat
Zzvtp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FOBK is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 2.84
Day Range
CAD 2.822.82
52-Week Range
3.14
Bid/Ask
CAD 0.00 / CAD 0.00
Market Cap
CAD 240.84 Mil
Volume/Avg
0 /

Key Statistics

Price/Earnings (Normalized)
Price/Sales
8.77
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

kneat.com Inc is in the business of developing and marketing a software application for modeling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed the Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance, which include product support services. The company geographically operates in North America, Europe and Asia Pacific, out of which it earns maximum revenue from North America.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Growth
Total Number of Employees
293

Comparables

Valuation

Metric
FOBK
AVDX
DND
Price/Earnings (Normalized)
61.12
Price/Book Value
11.173.341.75
Price/Sales
8.775.511.53
Price/Cash Flow
44.969.24
Price/Earnings
FOBK
AVDX
DND

Financial Strength

Metric
FOBK
AVDX
DND
Quick Ratio
1.530.391.22
Current Ratio
1.571.341.33
Interest Coverage
−6.90−2.99−0.19
Quick Ratio
FOBK
AVDX
DND

Profitability

Metric
FOBK
AVDX
DND
Return on Assets (Normalized)
−19.39%1.20%−2.27%
Return on Equity (Normalized)
−59.45%3.96%−10.72%
Return on Invested Capital (Normalized)
−28.37%2.31%4.78%
Return on Assets
FOBK
AVDX
DND
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GE HealthCare Technologies Inc Common Stock
GEHC
Fpxfdv$34.9 Bil
Veeva Systems Inc Class A
VEEV
ShvbhcnkhXrrsk$29.9 Bil
Solventum Corp
SOLV
Dmhc$9.4 Bil
Pro Medicus Ltd
PMCUF
Nxksfbj$9.1 Bil
HealthEquity Inc
HQY
Khyfwg$7.2 Bil
Tempus AI Inc Class A common stock
TEM
Pdh$6.6 Bil
M3 Inc
MTHRF
Wyqpkv$6.5 Bil
M3 Inc ADR
MTHRY
Zzlrxfz$6.5 Bil
Doximity Inc Class A
DOCS
Jnqhrj$5.5 Bil
R1 RCM Inc
RCM
Mfy$5.3 Bil

Sponsor Center